JPS63189484A - Pressure-sensitive adhesive composition for oral mucosal application agent - Google Patents
Pressure-sensitive adhesive composition for oral mucosal application agentInfo
- Publication number
- JPS63189484A JPS63189484A JP2143687A JP2143687A JPS63189484A JP S63189484 A JPS63189484 A JP S63189484A JP 2143687 A JP2143687 A JP 2143687A JP 2143687 A JP2143687 A JP 2143687A JP S63189484 A JPS63189484 A JP S63189484A
- Authority
- JP
- Japan
- Prior art keywords
- adhesive composition
- water
- patch
- softener
- vinylpyrrolidone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 239000004820 Pressure-sensitive adhesive Substances 0.000 title description 6
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 35
- 239000007864 aqueous solution Substances 0.000 claims abstract description 24
- 229920001577 copolymer Polymers 0.000 claims abstract description 24
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 21
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 21
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000845 maltitol Substances 0.000 claims abstract description 12
- 235000010449 maltitol Nutrition 0.000 claims abstract description 12
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 12
- 229940035436 maltitol Drugs 0.000 claims abstract description 12
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 5
- 239000000600 sorbitol Substances 0.000 claims abstract description 5
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims abstract description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 3
- 230000001070 adhesive effect Effects 0.000 claims description 45
- 239000000853 adhesive Substances 0.000 claims description 44
- 150000003839 salts Chemical class 0.000 claims description 21
- 210000002200 mouth mucosa Anatomy 0.000 claims description 16
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229940105990 diglycerin Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 34
- 210000000214 mouth Anatomy 0.000 abstract description 10
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 21
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 17
- 229940105329 carboxymethylcellulose Drugs 0.000 description 16
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 15
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 15
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 13
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 13
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 7
- 206010016807 Fluid retention Diseases 0.000 description 6
- 239000000123 paper Substances 0.000 description 6
- 239000010408 film Substances 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- -1 acrylic ester Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 201000001245 periodontitis Diseases 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920006264 polyurethane film Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 229920002799 BoPET Polymers 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- 208000005232 Glossitis Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 239000002655 kraft paper Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 208000003265 stomatitis Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- NBOCQTNZUPTTEI-UHFFFAOYSA-N 4-[4-(hydrazinesulfonyl)phenoxy]benzenesulfonohydrazide Chemical compound C1=CC(S(=O)(=O)NN)=CC=C1OC1=CC=C(S(=O)(=O)NN)C=C1 NBOCQTNZUPTTEI-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HLKZFSVWBQSKKH-UHFFFAOYSA-N but-3-enoic acid;1-ethenylpyrrolidin-2-one Chemical compound OC(=O)CC=C.C=CN1CCCC1=O HLKZFSVWBQSKKH-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 125000005909 ethyl alcohol group Chemical group 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920003117 medium viscosity grade hydroxypropyl cellulose Polymers 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- DVQHRBFGRZHMSR-UHFFFAOYSA-N sodium methyl 2,2-dimethyl-4,6-dioxo-5-(N-prop-2-enoxy-C-propylcarbonimidoyl)cyclohexane-1-carboxylate Chemical compound [Na+].C=CCON=C(CCC)[C-]1C(=O)CC(C)(C)C(C(=O)OC)C1=O DVQHRBFGRZHMSR-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000004357 third molar Anatomy 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、薄葉体状(皮膜状またはシート状)の口腔粘
膜貼付剤用の粘着剤組成物、特に、粘弾性的な柔軟性を
有し、粘着性・耐水性に優れた口腔粘膜貼付剤用の粘着
剤組成物に関する。Detailed Description of the Invention (Industrial Field of Application) The present invention relates to an adhesive composition for a thin film-like (film-like or sheet-like) oral mucosal patch, particularly an adhesive composition having viscoelastic flexibility. The present invention also relates to an adhesive composition for oral mucosa patch having excellent adhesiveness and water resistance.
(従来の技術)
口腔内粘膜の偏部や疾患(口内炎9ロ唇炎、舌炎、智歯
周囲炎、歯槽膿漏、歯肉炎など)部分に貼付してその箇
所を保護し治療するための製剤;および口腔内粘膜を通
して薬物を吸収させ全身的治療効果を得るための製剤と
しては9錠剤、トローチ錠、顆粒剤、散剤、シート状の
薄葉体などがある。(Prior technology) A preparation that is applied to uneven areas of the oral mucosa or diseased areas (stomatitis, lipitis, glossitis, periodontitis, alveolar pyorrhea, gingivitis, etc.) to protect and treat the affected areas. and preparations for absorbing drugs through the oral mucosa to obtain a systemic therapeutic effect include tablets, troches, granules, powders, and thin sheets.
錠剤、トローチ錠、顆粒剤などの製剤には2例えば、ヒ
ドロキシプロピルセルロースおよびポリアクリル酸また
はその塩を含む混合物からなる徐放性製剤(特公昭58
〜7605号公報に開示)やポリビニルピロリドン、ポ
リビニルアルコール、ポリエチレングリコール、アルギ
ン酸またはその塩。For preparations such as tablets, troches, and granules, for example, sustained-release preparations consisting of a mixture containing hydroxypropylcellulose and polyacrylic acid or its salt (Japanese Patent Publication No. 58
-7605), polyvinylpyrrolidone, polyvinyl alcohol, polyethylene glycol, alginic acid or a salt thereof.
および無水マレイン酸とメチルビニルエーテルとの交互
共重合体でなる群から選択される少なくとも一種のポリ
マーと、アクリル酸(共)重合体またはその塩との混合
物からなる口腔粘膜適用徐放性製剤(特開昭60−21
5622号公報に開示)がある。and an oral mucosal sustained-release preparation (specially Kaisho 60-21
(disclosed in Japanese Patent No. 5622).
しかし1錠剤、トローチ錠、顆粒剤などは貼付面積が小
さいため、薬物投与性が低く、シかも粘膜保護が不充分
である。柔軟性に欠けることから。However, single tablets, troches, granules, and the like have a small application area, resulting in poor drug administration and insufficient mucosal protection. Due to lack of flexibility.
貼付性も低い。Adhesiveness is also low.
このような欠点を解決するために2口腔粘膜用製剤を薄
葉体状とすることが提案されている。しかし9錠剤、ト
ローチ錠、顆粒剤などに用いられる組成物を薄葉体状に
加工しても、柔軟性・粘着性に欠けるため5口腔粘膜に
適用し得ない。耐水性に乏しく、短時間で溶解・分散す
る。しかも。In order to solve these drawbacks, it has been proposed to form bioral mucosal preparations into thin lamellar forms. However, even if the compositions used for tablets, troches, granules, etc. are processed into thin lamellar forms, they cannot be applied to the oral mucosa because they lack flexibility and adhesiveness. It has poor water resistance and dissolves and disperses in a short time. Moreover.
得られた薄葉体にはクランクが生じやすい。柔軟性・粘
着性を与えるべく、上記組成物に軟化剤を加えても、塑
性的な軟らかさは増すものの粘弾性的な柔軟性(伸縮性
のある柔軟性)が得られない。The resulting thin film is likely to be cranked. Even if a softener is added to the composition to impart flexibility and tackiness, although plastic softness increases, viscoelastic flexibility (stretchable flexibility) cannot be obtained.
このようなことから、薄葉体状の口腔粘膜用製剤を形成
するための粘着剤組成物が提緊されている。例えば、特
開昭59−232553号公報には、アクリル酸(共)
重合体もしくはその水溶性塩;カルボキシメチルセルロ
ースナトリウム、アルギン酸ナトリウムおよびヒドロキ
シエチルセルロースのうちの少なくとも一種;そしてグ
リセリンおよび/またはプロピレングリコールを主成分
とする粘着剤組成物が開示されている。また、特開昭5
9−19681/1号公報には、ゼラチンまたは寒天;
グルテン;カルボキシビニルポリマー;多価アルコール
:および酢酸ビニル樹脂またはガム類を含む粘着剤組成
物が開示されている。しかし、いずれの組成物も。For this reason, there is a need for an adhesive composition for forming a thin film-like preparation for oral mucosa. For example, in Japanese Patent Application Laid-open No. 59-232553, acrylic acid (co-)
A pressure-sensitive adhesive composition containing a polymer or a water-soluble salt thereof; at least one selected from sodium carboxymethyl cellulose, sodium alginate, and hydroxyethyl cellulose; and glycerin and/or propylene glycol is disclosed. Also, JP-A-5
9-19681/1, gelatin or agar;
Adhesive compositions are disclosed that include gluten; carboxyvinyl polymer; polyhydric alcohol; and vinyl acetate resin or gums. However, neither composition.
粘弾性的な柔軟性・粘着性が充分ではない。耐水性も不
足している。従って2口腔粘膜への適用は好ましくない
。Viscoelastic flexibility and adhesion are not sufficient. It also lacks water resistance. Therefore, application to the oral mucosa is not preferred.
(発明が解決しようとする問題点)
本発明は上記従来の問題点を解決するものであり、その
目的とするとごろは、粘弾性的な柔軟性を有し、粘着性
・耐水性に優れた口腔粘膜貼付剤用の粘着剤組成物を提
供することにある。本発明の他の目的は、薄葉体状の口
腔粘膜貼付剤を形成し得る口腔粘膜貼付剤用の粘着剤組
成物を提供することにある。本発明のさらに他の目的は
、粘弾性的な柔軟性・粘着性・耐水性を広範囲にわたっ
て調節し得る口腔粘膜貼付剤用の粘着剤組成物を提供す
ることにある。本発明のさらに他の目的は。(Problems to be Solved by the Invention) The present invention solves the above-mentioned conventional problems, and its purpose is to provide a material that has viscoelastic flexibility and excellent adhesiveness and water resistance. An object of the present invention is to provide an adhesive composition for an oral mucosal patch. Another object of the present invention is to provide an adhesive composition for an oral mucosal patch that can form a thin-film oral mucosal patch. Still another object of the present invention is to provide an adhesive composition for an oral mucosal patch that can control viscoelastic flexibility, adhesiveness, and water resistance over a wide range. Yet another object of the present invention.
乾燥時にて粘着性を有するかまたは水分の吸収によって
粘着性が発現する口腔粘膜貼付剤用の粘着剤組成物を提
供することにある。本発明のさらに他の目的は2口腔内
にて最終的に溶解・消失し得る口腔粘膜貼付剤用の粘着
剤組成物を提供することにある。本発明のさらに他の目
的は1人体に毒性や刺激性を有しない口腔粘膜貼付剤用
の粘着剤組成物を提供することにある。本発明のさらに
他の目的は、安価にして得られる口腔粘膜貼付剤用の粘
着剤組成物を提供することにある。An object of the present invention is to provide an adhesive composition for an oral mucosal patch that is sticky when dry or becomes sticky when moisture is absorbed. Still another object of the present invention is to provide an adhesive composition for an oral mucosal patch that can finally dissolve and disappear within the oral cavity. Still another object of the present invention is to provide an adhesive composition for an oral mucosal patch that is not toxic or irritating to the human body. Still another object of the present invention is to provide an adhesive composition for an oral mucosal patch that can be obtained at low cost.
(問題点を解決するための手段)
本発明は、ビニルピロリドン(共)重合体と保水性軟化
剤とを組み合わせることにより、粘弾性的な柔軟性を有
しかつ粘着性に優れた粘着剤組成物が得られる;しかも
、この組成物にさらに1%水溶液の20℃での粘度が1
000センチボイズ以上であるカルボキシメチルセルロ
ースまたはその塩を配合すれば、粘着剤組成物の耐水性
が改善される。(Means for Solving the Problems) The present invention provides an adhesive composition that has viscoelastic flexibility and excellent adhesiveness by combining a vinylpyrrolidone (co)polymer and a water-retaining softener. Furthermore, this composition has a viscosity of 1% aqueous solution at 20°C of 1.
If carboxymethylcellulose or a salt thereof having a cell diameter of 0,000 centivoids or more is blended, the water resistance of the adhesive composition is improved.
との発明者の知見にもとづいて完成された。It was completed based on the inventor's knowledge.
本発明の口腔粘膜貼付剤用の粘着剤組成物は。The adhesive composition for oral mucosal patch of the present invention is as follows.
ビニルピロリドン(共)重合体、1%水溶液の20℃で
の粘度が1000センチボイズ以上であるカルボキシメ
チルセルロースまたはその塩、および保水性軟化剤を含
有し、そのことにより上記目的が達成される。The above object is achieved by containing a vinylpyrrolidone (co)polymer, carboxymethylcellulose or a salt thereof having a viscosity of 1% aqueous solution at 20°C of 1000 centivoise or more, and a water-retaining softener.
ビニルピロリドン(共)重合体と上記カルボキシメチル
セルロースまたはその塩との重量比が95:5から60
: 40.好ましくは90 : 10から65 :
35であり、かつ1両者の合計量100重量部に対し、
保水性軟化剤は20〜400重量部、好ましくは50〜
300重量部の範囲で含有される。保水性軟化剤の上限
量は、グリセリンまたはジグリセリンの場合には200
重量部、トリグリセリンの場合には250重量部、ソル
ビトールの場合には300重量部、そしてマルチトール
の場合には400重量部とされる。ビニルピロリドン(
共)重合体の量が上記範囲よりも過少であると、得られ
た粘着剤組成物の粘弾性的な柔軟性・粘着性が低下する
。逆に、ビニルピロリドン(共)重合体の量が過剰であ
り、上記カルボキシメチルセルロースまたはその塩が過
少であると、耐水性が不足するため、水により容易に溶
解・消失する。保水性軟化剤の量は、ビニルピロリドン
(共)重合体と上記カルボキシメチルセルロースまたは
その塩との合計量を基準として決定される。保水性軟化
剤の星が過少であると、所望の柔軟性・粘着性が得られ
ない。保水性軟化剤の量が過大であると、耐水性が低下
する。The weight ratio of the vinylpyrrolidone (co)polymer and the above carboxymethyl cellulose or its salt is 95:5 to 60
: 40. Preferably 90:10 to 65:
35, and 1 for the total amount of 100 parts by weight of both,
The water retention softener is 20 to 400 parts by weight, preferably 50 to 400 parts by weight.
It is contained in a range of 300 parts by weight. The upper limit of the water retention softener is 200% in the case of glycerin or diglycerin.
The parts by weight are 250 parts by weight in the case of triglycerin, 300 parts by weight in the case of sorbitol, and 400 parts by weight in the case of maltitol. Vinylpyrrolidone (
If the amount of the co)polymer is less than the above range, the viscoelastic flexibility and adhesiveness of the resulting pressure-sensitive adhesive composition will decrease. On the other hand, if the amount of vinylpyrrolidone (co)polymer is excessive and the amount of carboxymethylcellulose or its salt is too little, water resistance will be insufficient and it will easily dissolve and disappear in water. The amount of the water-retaining softener is determined based on the total amount of the vinylpyrrolidone (co)polymer and the carboxymethyl cellulose or its salt. If the water retention softener has too few stars, the desired flexibility and adhesiveness cannot be obtained. If the amount of water-retaining softener is excessive, water resistance will decrease.
ビニルピロリドン(共)重合体には、ポリビニルピロリ
ドン、ビニルピロリドン−酢酸ビニル共重合体などがあ
る。この共重合体には1例えば。Vinylpyrrolidone (co)polymers include polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, and the like. This copolymer has one example.
アクリル酸エステルが20重量%以下の割合で含有され
てもよい。The acrylic ester may be contained in a proportion of 20% by weight or less.
カルボキシメチルセルロースは、単独で用いると、得ら
れた口腔粘膜貼付剤が崩壊しやすくなるため5通常、塩
の形に変えられるかまたはカルボキシメチルセルロース
の塩と併用される。カルボキシメチルセルロースの塩に
は2例えば、カルボキシメチルセルロースナトリウムが
ある。If carboxymethylcellulose is used alone, the resulting oral mucosal patch tends to disintegrate5, so it is usually converted into a salt form or used in combination with a salt of carboxymethylcellulose. Examples of salts of carboxymethylcellulose include sodium carboxymethylcellulose.
保水性軟化剤には1例えば、グリセリン、ジグリセリン
、トリグリセリン、ソルビトール、マルチトールがある
。この軟化剤は、得られた粘着剤組成物に柔軟性、粘着
性を付与するとともに、水溶解性の調整に用いられる。Water retention softeners include, for example, glycerin, diglycerin, triglycerin, sorbitol, and maltitol. This softener imparts flexibility and tackiness to the resulting pressure-sensitive adhesive composition, and is also used to adjust water solubility.
この粘着性付与効果は、液体である軟化剤が直接与える
効果と、空気中から該軟化剤に吸収される水による効果
とであると考えられる。This tackifying effect is thought to be due to the direct effect of the liquid softener and the effect of water absorbed by the softener from the air.
ビニルピロリドン(共)重合体の市販品には。Commercially available vinylpyrrolidone (co)polymers include:
例えば、コリトンに−90(ポリビニルピロリドン。For example, Koliton-90 (polyvinylpyrrolidone).
高粘度品)、コリトンに一’to (ポリビニルピロリ
ドン、中粘度孔)、コリトンに−25(ポリビニルピロ
リドン、低粘度品)、コリトンVA−64(ビニルピロ
リドン−酢酸ビニル(6/4)共重合体)(いずれもB
ASF社製)がある。Koliton ni'to (polyvinylpyrrolidone, medium viscosity pore), Koliton -25 (polyvinylpyrrolidone, low viscosity product), Koliton VA-64 (vinylpyrrolidone-vinyl acetate (6/4) copolymer) ) (Both are B
(manufactured by ASF).
カルボキシメチルセルロースまたはその塩の市販品には
9例えば、セロゲンーF−3H(カルボキシメチルセル
ロースナトリウム、第一工業製薬社製。Commercially available carboxymethylcellulose or its salts include 9, for example, Cellogen-F-3H (sodium carboxymethylcellulose, manufactured by Dai-ichi Kogyo Seiyaku Co., Ltd.).
1%水溶液の粘度は20℃で約1300cps ) 、
セロゲンーFBSII−6(カルボキシメチルセルロー
スナトリウム、第一工業製薬社製。1%水溶液の粘度は
20℃で約3500cps ) 、セロゲン−FBSH
−10(カルボキシメチルセルロースナトリウム、第一
工業製薬社製。1%水溶液の粘度は20℃で約5000
cps ) 、セロゲン−FBSH−12(カルボキシ
メチルセルロースナトリウム、第一工業製薬社製。1%
水溶液の粘度は20℃で約8000cps ) 、 C
MC−ダイセル−2100(カルボキシメチルセルロー
スナトリウム、ダイセル化学社製、1%水溶液の粘度は
20℃で約3000cps) 。The viscosity of a 1% aqueous solution is approximately 1300 cps at 20°C),
Celogen-FBSII-6 (sodium carboxymethyl cellulose, manufactured by Daiichi Kogyo Seiyaku Co., Ltd. The viscosity of a 1% aqueous solution is approximately 3500 cps at 20°C), Celogen-FBSH
-10 (sodium carboxymethyl cellulose, manufactured by Daiichi Kogyo Seiyaku Co., Ltd. The viscosity of a 1% aqueous solution is approximately 5000 at 20°C.
cps), Celogen-FBSH-12 (sodium carboxymethylcellulose, manufactured by Daiichi Kogyo Seiyaku Co., Ltd. 1%
The viscosity of the aqueous solution is approximately 8000 cps at 20°C), C
MC-Daicel-2100 (carboxymethylcellulose sodium, manufactured by Daicel Chemical Co., Ltd., viscosity of 1% aqueous solution is about 3000 cps at 20°C).
CMC−ダイセル−2260(カルボキシメチルセルロ
ースナトリウム、ダイセル化学社製、1%水溶液の粘度
は20℃で約5000cps ) 、 CMC−ダイセ
ル−2170(カルボキシメチルセルロースナトリウム
、ダイセル化学社製、1%水溶液の粘度は20℃で約7
000cps )がある。CMC-Daicel-2260 (sodium carboxymethyl cellulose, manufactured by Daicel Chemical Co., Ltd., viscosity of 1% aqueous solution is approximately 5000 cps at 20°C), CMC-Daicel-2170 (sodium carboxymethyl cellulose, manufactured by Daicel Chemical Company, viscosity of 1% aqueous solution is approximately 20 cps) Approximately 7 degrees Celsius
000cps).
本発明の粘着剤組成物には、ビニルピロリドン(共)重
合体、1%水溶液の20°Cでの粘度が1000センチ
ポイズ以上であるカルボキシメチルセルロースまたはそ
の塩、および保水性軟化剤の他に。The adhesive composition of the present invention includes, in addition to vinylpyrrolidone (co)polymer, carboxymethylcellulose or a salt thereof having a viscosity of 1% aqueous solution at 20°C of 1000 centipoise or more, and a water-retaining softener.
必要に応じて、水溶性高分子、有機充填剤、無機充填剤
、架橋剤1着色剤、防腐剤、安定剤、香料。Water-soluble polymer, organic filler, inorganic filler, crosslinking agent 1 coloring agent, preservative, stabilizer, fragrance, if necessary.
着味剤などが添加される。これらの添加剤は、全成分中
において、20%以下の割合で加えられる。Flavoring agents etc. are added. These additives are added in a proportion of 20% or less of the total components.
20%を上まわると、粘着剤組成物の物性(粘弾性的な
柔、軟性、粘着性、耐水性など)が損なわれる。If it exceeds 20%, the physical properties of the adhesive composition (viscoelastic softness, softness, adhesiveness, water resistance, etc.) will be impaired.
本発明の粘着剤組成物は9例えば1次のようにして口腔
粘膜貼付剤に製造される。The adhesive composition of the present invention is manufactured into an oral mucosal patch in the following manner, for example.
ビニルピロリドン(共)重合体、1%水溶液の20℃で
の粘度が1000センチボイズ以上であるカルボキシメ
チルセルロースまたはその塩、保水性軟化剤の各成分を
水、アルコールなどに別々に溶解させ、所定の成分比率
となるように各溶液を混合することにより、粘着剤組成
物溶液が調製される。Vinylpyrrolidone (co)polymer, carboxymethyl cellulose or its salt having a viscosity of 1% aqueous solution at 20°C of 1000 centiboise or more, and a water-retention softener are separately dissolved in water, alcohol, etc., and the desired components are dissolved. A pressure-sensitive adhesive composition solution is prepared by mixing each solution in a proportionate manner.
この溶液を1片面がシリコーン剥離性のポリエチレンテ
レフタレート(PUT)フィルムの剥離性面に流延、乾
燥する。さらにその表面にシリコーン剥離祇を保護の目
的で重ねる。PETフィルムを剥がし取ることにより、
Wj葉体状の口腔粘膜貼付剤が得られる。PETフィル
ムに代えて、工程紙(OPPフィルムとクラフト紙との
ラミネート体)を用い。This solution is cast onto the release side of a silicone release polyethylene terephthalate (PUT) film on one side and dried. Furthermore, a silicone release layer is layered on the surface for protection. By peeling off the PET film,
A Wj leaflet-shaped oral mucosa patch is obtained. Instead of PET film, use engineered paper (a laminate of OPP film and kraft paper).
OPP面上に仮接着状態としたポリエーテル系ポリウレ
タンフィルムの表面に粘着剤組成物溶液を流延、乾燥し
てもよい。この場合、工程紙を剥離して口腔粘膜貼付剤
が得られる。薄葉体の厚さには特に制限はなく、50〜
500μmが好ましく、100〜200μmがより好ま
しい。The adhesive composition solution may be cast on the surface of the polyether-based polyurethane film that has been temporarily bonded onto the OPP surface and dried. In this case, the oral mucosa patch is obtained by peeling off the process paper. There is no particular limit to the thickness of the thin film, and it is from 50 to
500 μm is preferable, and 100 to 200 μm is more preferable.
(作用)
本発明によれば、このように、粘弾性的な柔軟性を有し
、粘着性・耐水性に優れた口腔粘膜貼付剤用の粘着剤組
成物が得られる。この粘着剤組成物は、ビニルピロリド
ン(共)重合体と保水性軟化剤により、粘弾性的な柔軟
性を有しかつ粘着性に優れた組成物とされ、これにさら
に1%水溶液の20’Cでの粘度が1000センチポイ
ズ以上であるカルボキシメチルセルロースまたはその塩
を加えることにより、耐水性が向上する。耐水性は、ビ
ニルピロリドン(共)重合体とこのカルボキシメチルセ
ルロースまたはその塩との相乗効果により。(Function) According to the present invention, an adhesive composition for an oral mucosa patch having viscoelastic flexibility and excellent adhesiveness and water resistance can be obtained. This pressure-sensitive adhesive composition has viscoelastic flexibility and excellent adhesiveness due to the vinylpyrrolidone (co)polymer and the water-retaining softener. Water resistance is improved by adding carboxymethyl cellulose or a salt thereof having a viscosity of 1000 centipoise or more at C. Water resistance is due to the synergistic effect of vinylpyrrolidone (co)polymer and carboxymethylcellulose or its salt.
さらに改善される。Further improvements will be made.
本発明では、ビニルピロリドン(共)重合体。In the present invention, vinylpyrrolidone (co)polymer.
1%水溶液の20°Cでの粘度が1000センチポイズ
以上であるカルボキシメチルセルロースまたはその塩、
保水性軟化剤の比率を変えることにより、粘弾性的な柔
軟性・粘着性・耐水性を広範囲にわたって調節し得る。Carboxymethylcellulose or a salt thereof having a viscosity of 1000 centipoise or more at 20°C in a 1% aqueous solution,
By varying the ratio of water-retaining softeners, viscoelastic flexibility, tackiness, and water resistance can be adjusted over a wide range.
ビニルピロリドン(共)重合体の割合を多くすれば、粘
着性が高くなる。他方。The higher the proportion of vinylpyrrolidone (co)polymer, the higher the tackiness. On the other hand.
上記カルボキシメチルセルロースまたはその塩を多くす
れば、耐水性が向上する。粘弾性的な柔軟性および粘着
性を得るには、ビニルピロリドン(共)重合体と上記カ
ルボキシメチルセルロースまたはその塩との比率に応じ
て、保水性軟化剤が加えられる。保水性軟化剤の添加量
により、乾燥時にて粘着性を有するかまたは水分の吸収
によって粘着性を発現するかも決定される。保水性軟化
剤の量が多ければ、乾燥時でも粘着性を呈する。しかし
、耐水性は低下し、水溶解性が増大する。保水性軟化剤
が少ないと、粘着性が低下する。If the amount of carboxymethyl cellulose or its salt is increased, water resistance will be improved. In order to obtain viscoelastic flexibility and tackiness, a water-retaining softener is added depending on the ratio of the vinylpyrrolidone (co)polymer to the carboxymethyl cellulose or its salt. Depending on the amount of the water-retaining softener added, it is also determined whether the adhesive becomes sticky upon drying or becomes sticky upon absorption of moisture. If the amount of water-retaining softener is large, it will become sticky even when dry. However, water resistance decreases and water solubility increases. If there is less water retention softener, the tackiness will be reduced.
本発明の粘着剤組成物は、また1口腔内にて最終的に溶
解・消失し得る。それゆえ、貼付後に剥離する必要はな
い。The adhesive composition of the present invention can also finally dissolve and disappear within one oral cavity. Therefore, there is no need to peel it off after application.
(実施例) 以下に本発明を実施例について述べる。(Example) The present invention will be described below with reference to examples.
1Llfi肛
(1)粘着剤組成物の調製
ポリビニルピロリドン(コリトンに−90,BASF社
製)90重量部
カルボキシメチルセルロースナトリウム(セロゲンーF
BS11−12.第一工業製薬社製)10重量部マルチ
トール 200重量部上記処方を混
合し、粘着剤組成物溶液を調製した。ただし、ポリビニ
ルピロリドンは25%水溶液として、カルボキシメチル
セルロースナトリウムは水/エチルアルコール混合溶媒
(9515重量比)の4%溶液として、そしてマルチト
ールは80%水溶液としてそれぞれ別々に溶解させ、上
記組成となるように各溶液を混合した。(1) Preparation of adhesive composition Polyvinylpyrrolidone (Koriton-90, manufactured by BASF) 90 parts by weight Sodium carboxymethyl cellulose (Celogen-F
BS11-12. (manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) 10 parts by weight Maltitol 200 parts by weight The above formulations were mixed to prepare an adhesive composition solution. However, polyvinylpyrrolidone was dissolved separately as a 25% aqueous solution, sodium carboxymethylcellulose was dissolved as a 4% solution in a mixed solvent of water/ethyl alcohol (9515 weight ratio), and maltitol was dissolved as an 80% aqueous solution to obtain the above composition. Each solution was mixed.
この粘着剤組成物は乾燥時にて粘着性を有するため、す
ぐに接着が可能である。Since this adhesive composition has tackiness when dry, it can be bonded immediately.
(2)口腔粘膜貼付剤の作製
エチルセルロース(エトセル45cps 、ダウケミカ
ル社製)40重量部およびヒドロキシプロピルセルロー
ス(日曹HPC−M、日本曹達社製)60重量部の8%
エチルアルコール溶液を調製した。この溶液を9片面が
シリコーン剥離性のポリエチレンテレフタレート(PE
T)フィルム(厚さ50μm)の剥離性面に、30μm
厚で塗工した。この塗工面に。(2) Preparation of oral mucosal patch 8% of 40 parts by weight of ethyl cellulose (Ethocel 45 cps, manufactured by Dow Chemical Company) and 60 parts by weight of hydroxypropyl cellulose (Nisso HPC-M, manufactured by Nippon Soda Company)
An ethyl alcohol solution was prepared. This solution was applied to 9 polyethylene terephthalate (PE) with silicone releasable surface on one side.
T) 30 μm on the peelable side of the film (thickness: 50 μm)
It was coated thickly. on this coated surface.
(11で得られた粘着剤組成物溶液を、乾燥後の厚さが
150μmとなるように流延・乾燥し、その表面に保護
の目的でシリコーン剥離紙を重ねた。この表面は、乾燥
時にも粘着性を有していた。得られた積層体からPET
フィルムを剥離することにより。(The adhesive composition solution obtained in step 11 was cast and dried to a dry thickness of 150 μm, and a silicone release paper was layered on the surface for protection. The resulting laminate also had adhesive properties.
By peeling off the film.
口腔粘膜貼付剤が作製された。この貼付剤は、必要に応
じて薬効成分が含浸処理されて9例えば。An oral mucosal patch was prepared. This patch may be impregnated with a medicinal ingredient if necessary, for example.
10m×2CI11に裁断される。製品としては、適当
な防湿性包装袋に入れて供給され、貼付時にはシリコー
ン剥離紙が剥がされる。Cut to 10m x 2CI11. The product is supplied in a suitable moisture-proof packaging bag, and the silicone release paper is peeled off at the time of application.
(3)口腔粘膜貼付剤の評価
(2)で得られた口腔粘膜貼付剤を1 cm X 1
cmに裁断し1口腔内の頬部粘膜面に貼付した。その結
果。(3) Evaluation of oral mucosal patch The oral mucosal patch obtained in (2) was placed in a 1 cm x 1
It was cut into cm pieces and pasted on the buccal mucosal surface of one oral cavity. the result.
この貼付剤は約140分間保持され、最終的には溶解に
より自然消滅した。This patch was kept for about 140 minutes and eventually disappeared naturally due to dissolution.
尖滌拠1
(1)粘着剤組成物の調製
ポリビニルピロリドン(コリトンに−90,BASF社
製)80重量部
カルボキシメチルセルロースナトリウム(セロゲンF−
BSI+−6.第一工業製薬社製) 20重置部
グリセリン 30重量部マルチ
トール 50重量部上記処方を混
合し、粘着剤組成物溶液を調製した。ただし、ポリビニ
ルピロリドンは25%水溶液として、カルボキシメチル
セルロースナトリウムは水/エチルアルコール混合溶媒
(9515重量比)の8%溶液として、そしてマルチト
ールは80%水溶液としてそれぞれ別々に溶解させ、こ
れにグリセリンを加えて上記組成となるように各溶液を
混合した。Tip 1 (1) Preparation of adhesive composition 80 parts by weight of polyvinylpyrrolidone (Koriton-90, manufactured by BASF) Sodium carboxymethyl cellulose (Celogen F-
BSI+-6. (manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) 20 parts Glycerin 30 parts Maltitol 50 parts by weight The above formulations were mixed to prepare an adhesive composition solution. However, polyvinylpyrrolidone was dissolved as a 25% aqueous solution, sodium carboxymethyl cellulose was dissolved as an 8% solution in a water/ethyl alcohol mixed solvent (9515 weight ratio), and maltitol was dissolved as an 80% aqueous solution, and glycerin was added to these. Each solution was mixed to obtain the above composition.
この粘着剤組成物は、乾燥時にはわずかに粘着性を有し
、水分の吸収によって粘着性が増大する。This adhesive composition is slightly tacky when dry and increases in tackiness upon absorption of moisture.
この組成物を用いた貼付剤を口腔粘膜に貼付すれば、実
施例1で作製された貼付剤と同程度の保持時間を与え、
最終的には溶解により自然に消°滅する。When a patch using this composition is applied to the oral mucosa, it gives a retention time comparable to that of the patch prepared in Example 1,
Eventually, it will disappear naturally through dissolution.
実詣斑主
(1)粘着剤組成物の調製
ポリビニルピロリドン(コリトンに−90,BASF社
製) 70重量部
カルボキシメチルセルロースナトリウム(CMC−ダイ
セル2170.ダイセル化学社製)30重量部ソルビト
ール 20重世部マルチトール
60重量部上記処方を混合し、粘
着剤組成物溶液を調製した。ただし、ポリビニルピロリ
ドンは25%水溶液として、カルボキシメチルセルロー
スナトリウムは水/エチルアルコール混合溶媒(951
5重量比)の6%溶液として、そしてマルチトールは8
0%水溶液としてそれぞれ別々に溶解させ、上記組成と
なるように各溶液を混合した。Fruit patch main (1) Preparation of adhesive composition Polyvinylpyrrolidone (Koriton-90, manufactured by BASF) 70 parts by weight Sodium carboxymethyl cellulose (CMC-Daicel 2170, manufactured by Daicel Chemical Co., Ltd.) 30 parts by weight Sorbitol 20 parts by weight Maltitol
60 parts by weight of the above formulation was mixed to prepare an adhesive composition solution. However, polyvinylpyrrolidone is a 25% aqueous solution, and carboxymethylcellulose sodium is a water/ethyl alcohol mixed solvent (951
5% by weight) and maltitol as a 6% solution of 8
Each was dissolved separately as a 0% aqueous solution, and each solution was mixed to give the above composition.
この粘着剤組成物は柔軟ではあるが乾燥時には粘着性を
有せず、水分を吸収することにより粘着性が発現する。Although this adhesive composition is flexible, it does not have tackiness when dry, and becomes tackiness by absorbing moisture.
この組成物を用いた貼付剤を口腔粘膜に貼付すれば、実
施例1で作製された貼付剤の1.5〜2倍程度の保持時
間を与え、最終的には溶解により自然消滅する。If a patch using this composition is applied to the oral mucosa, it will last approximately 1.5 to 2 times as long as the patch prepared in Example 1, and will eventually disappear naturally by dissolution.
(2)口腔粘膜貼付剤の作製
工程紙(OPPフィルムとクラフト紙とのラミネート体
)のOPP面上に仮接着状態にあるポリエーテル系ポリ
ウレタンフィルム(厚さ50μm)の表面上に、、 (
11で得られた粘着剤組成物溶液を、乾燥後の厚さが1
30μmとなるように流延・乾燥した。(2) Production process of oral mucosal adhesive patch On the surface of the polyether-based polyurethane film (thickness 50 μm) that is temporarily adhered to the OPP surface of the paper (laminate of OPP film and kraft paper),
The adhesive composition solution obtained in step 11 was dried to a thickness of 1
It was cast and dried to a thickness of 30 μm.
次いで、得られた積層体から工程紙を剥離することによ
り1口腔粘膜貼付剤が作製された。この貼付剤は、乾燥
時には粘着性を有しないため、取扱いが容易である。水
分を吸収することにより、粘着性が発現する。この貼付
剤は、適当な大きさに裁断され1口腔内損傷部の保護や
経粘膜用錠剤の局所固定などに好適に用いられる。Next, one oral mucosa patch was prepared by peeling off the processing paper from the obtained laminate. This patch is easy to handle because it is not sticky when dry. Adhesiveness develops by absorbing moisture. This patch is cut into an appropriate size and suitably used for protecting an injured part of the oral cavity or for local fixation of transmucosal tablets.
(3)口腔粘膜貼付剤の評価
(2)で得られた口腔粘膜貼付剤をl c(B X l
crnに裁断し1口腔内の頬部粘膜面に貼付した。そ
の結果。(3) Evaluation of oral mucosal patch The oral mucosal patch obtained in (2) was
It was cut into crn pieces and pasted on the buccal mucosal surface of one oral cavity. the result.
この貼付剤は約300分間保持され、最終的にはポリエ
ーテル系ポリウレタンフィルムが残り、これは自然に剥
がれた。This patch was kept for about 300 minutes, and finally a polyether-based polyurethane film remained, which peeled off naturally.
尖施拠土
ポリビニルピロリドン(コリトンに−30,BASF社
製)35重足部
ビニルピロリドン−酢酸ビニル共重合体(コリドアVA
−64、BASF社製)30重量部カルボキシメチルセ
ルロースナトリウム(CMCダイセル−2260,ダイ
セル化学社製)35重量部マルチトール
300重量部上記処方を混合し、粘着剤組成物溶
液を調製した。ただし、ポリビニルピロリドンは40%
水溶液として、ビニルピロリドン−酢酸ビニル共重合体
は30%水溶液として、カルボキシメチルセルロースナ
トリウムは水/エチルアルコール混合溶媒(9515重
量比)の12%溶液として、そしてマルチトールは80
%水溶液としてそれぞれ別々に溶解させ、上記組成とな
るように各溶液を混合した。Polyvinyl pyrrolidone (Koriton-30, manufactured by BASF) 35 heavy feet Vinyl pyrrolidone-vinyl acetate copolymer (Koridoor VA
-64, manufactured by BASF) 30 parts by weight Sodium carboxymethylcellulose (CMC Daicel-2260, manufactured by Daicel Chemical) 35 parts by weight Maltitol
300 parts by weight of the above formulation was mixed to prepare an adhesive composition solution. However, polyvinylpyrrolidone is 40%
As aqueous solutions, vinylpyrrolidone-vinyl acetate copolymer is used as a 30% aqueous solution, sodium carboxymethylcellulose is used as a 12% solution in a water/ethyl alcohol mixed solvent (9515 weight ratio), and maltitol is used as a 80% aqueous solution.
% aqueous solution, and the solutions were mixed to give the above composition.
この粘着剤組成物は非常に柔軟でかつ乾燥時にも強い粘
着性を示した。This adhesive composition was very flexible and showed strong tack even when dry.
(2)口腔粘膜貼付剤の作製
(1)で得られた粘着剤組成物溶液を用い、実施例1と
同様の方法により1口腔粘膜貼付剤を作製した。ただし
、エチルセルロースは30重量部、そしてヒドロキシプ
ロピルセルロースは70重量部で配合し、これらのエチ
ルアルコール
で塗工した。(2) Preparation of oral mucosal patch 1 An oral mucosal patch was produced in the same manner as in Example 1 using the adhesive composition solution obtained in (1). However, 30 parts by weight of ethyl cellulose and 70 parts by weight of hydroxypropyl cellulose were blended, and these ethyl alcohols were used for coating.
(3)口腔粘膜貼付剤の評価
(2)で得られた口腔粘膜貼付剤をl cm X 1
cmに裁断し,口腔内の頬部粘膜面に貼付した。その結
果。(3) Evaluation of oral mucosal patch The oral mucosal patch obtained in (2) was 1 cm x 1
It was cut into cm pieces and pasted on the buccal mucosal surface of the oral cavity. the result.
この貼付剤は約90分間保持され,最終的には)岩屑に
より自然消滅した。This patch was retained for about 90 minutes and eventually disappeared naturally due to rock debris.
(発明の効果) 本発明の口腔粘膜貼付剤用の粘着剤組成物は。(Effect of the invention) The adhesive composition for oral mucosal patch of the present invention is as follows.
このように、粘弾性的な柔軟性を有し,粘着性・耐水性
に優れている。それゆえ、この組成物によれば.薄葉体
状の口腔粘膜貼付剤を形成し得る。As described above, it has viscoelastic flexibility and is excellent in adhesiveness and water resistance. Therefore, according to this composition. A lamellar oral mucosa patch can be formed.
耐水性に優れるため,口腔内で一定時間保持され得る。Because it has excellent water resistance, it can be retained in the oral cavity for a certain period of time.
粘着剤組成物の粘弾性的な柔軟性・粘着性・耐水性は.
広範囲にわたって調節が可能である。The viscoelastic flexibility, adhesiveness, and water resistance of the adhesive composition.
Adjustment is possible over a wide range.
従って,得られた口腔粘膜貼付剤の口腔内での保持時間
が調節できる。この粘着剤組成物は,乾燥時にて粘着性
を有するかまたは水分の吸収によって粘着性が発現する
。しかも、この組成物は耐水性とともに水溶解性も有す
るため.口腔内にて最終的に溶解・消失し得る。人体に
毒性や刺激性を有しないうえに,安価にて得られる。Therefore, the retention time of the obtained oral mucosal patch in the oral cavity can be adjusted. This adhesive composition has tackiness when dry or becomes tackiness by absorbing moisture. Moreover, this composition has both water resistance and water solubility. It may eventually dissolve and disappear in the oral cavity. It is not toxic or irritating to the human body, and can be obtained at low cost.
このようなことから、本発明の口腔粘膜貼付剤用の粘着
剤組成物は,口腔内粘膜の偏部や疾患(口内炎,ロ唇炎
,舌炎,智歯周囲炎,歯槽膿漏。For this reason, the adhesive composition for the oral mucosal patch of the present invention can be used to treat localized areas of the oral mucosa and diseases (stomatitis, lochitis, glossitis, wisdom teeth periodontitis, alveolar pyorrhea).
歯肉炎など)部分に貼付してその箇所を保護し治療する
ための製剤;および口腔内粘膜を通して薬物を吸収させ
全身的治療効果を得るための製剤として有効に利用され
得る。It can be effectively used as a preparation to be applied to areas (such as gingivitis) to protect and treat the area; and a preparation to absorb drugs through the oral mucosa to obtain a systemic therapeutic effect.
Claims (1)
℃での粘度が1000センチポイズ以上であるカルボキ
シメチルセルロースまたはその塩、および保水性軟化剤
を含有する口腔粘膜貼付剤用の粘着剤組成物。 2、前記ビニルピロリドン(共)重合体と前記カルボキ
シメチルセルロースまたはその塩との重量比が95:5
から60:40であり、かつ、両者の合計量100重量
部に対し、前記保水性軟化剤が20〜400重量部の範
囲で含有された特許請求の範囲第1項に記載の口腔粘膜
貼付剤用の粘着剤組成物。 3、前記保水性軟化剤が、グリセリン、ジグリセリン、
トリグリセリン、ソルビトールおよびマルチトールのう
ちの少なくとも一種である特許請求の範囲第1項に記載
の口腔粘膜貼付剤用の粘着剤組成物。[Claims] 1. Vinylpyrrolidone (co)polymer, 1% aqueous solution of 20
An adhesive composition for an oral mucosal patch containing carboxymethyl cellulose or a salt thereof having a viscosity of 1000 centipoise or more at °C, and a water-retaining softener. 2. The weight ratio of the vinylpyrrolidone (co)polymer and the carboxymethyl cellulose or its salt is 95:5.
The oral mucosa patch according to claim 1, wherein the water-retaining softener is contained in an amount of 20 to 400 parts by weight based on 100 parts by weight of the total amount of both. Adhesive composition for. 3. The water retention softener is glycerin, diglycerin,
The adhesive composition for an oral mucosal patch according to claim 1, which is at least one of triglycerin, sorbitol, and maltitol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2143687A JPS63189484A (en) | 1987-01-30 | 1987-01-30 | Pressure-sensitive adhesive composition for oral mucosal application agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2143687A JPS63189484A (en) | 1987-01-30 | 1987-01-30 | Pressure-sensitive adhesive composition for oral mucosal application agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63189484A true JPS63189484A (en) | 1988-08-05 |
Family
ID=12054922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2143687A Pending JPS63189484A (en) | 1987-01-30 | 1987-01-30 | Pressure-sensitive adhesive composition for oral mucosal application agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63189484A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0717761A1 (en) * | 1993-08-19 | 1996-06-26 | Cygnus Therapeutic Systems | Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
JP2000186269A (en) * | 1998-10-13 | 2000-07-04 | Lintec Corp | Ninhydrin-containing pressure-sensitive adhesive composition and sheet for detecting amino compound |
JP2004534030A (en) * | 2001-05-14 | 2004-11-11 | スリーエム イノベイティブ プロパティズ カンパニー | System for delivering cosmetics and pharmaceuticals |
JP2020526579A (en) * | 2017-06-29 | 2020-08-31 | スカイライン バイオサイエンシズ,エルエルシー | Isotretinoin oral mucosal preparation and its usage |
-
1987
- 1987-01-30 JP JP2143687A patent/JPS63189484A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0717761A1 (en) * | 1993-08-19 | 1996-06-26 | Cygnus Therapeutic Systems | Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
EP0717761A4 (en) * | 1993-08-19 | 1998-01-07 | Cygnus Therapeutic Systems | Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
JP2000186269A (en) * | 1998-10-13 | 2000-07-04 | Lintec Corp | Ninhydrin-containing pressure-sensitive adhesive composition and sheet for detecting amino compound |
JP2004534030A (en) * | 2001-05-14 | 2004-11-11 | スリーエム イノベイティブ プロパティズ カンパニー | System for delivering cosmetics and pharmaceuticals |
JP2020526579A (en) * | 2017-06-29 | 2020-08-31 | スカイライン バイオサイエンシズ,エルエルシー | Isotretinoin oral mucosal preparation and its usage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4619894B2 (en) | Drug carrier device suitable for delivery of drug compounds to mucosal surfaces | |
CA2268187C (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
KR100406722B1 (en) | Transdermal drug delivery system using acrylate adhesive with good water absorbability | |
US5900247A (en) | Mucoadhesive pharmaceutical composition for the controlled release of active principles | |
EP1713450B1 (en) | Rapidly dissolving film for delivery of an active agent | |
US6585997B2 (en) | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds | |
US6103266A (en) | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues | |
JPH0247962B2 (en) | ||
JP2007211030A (en) | Pharmaceutical gel preparation applicable to mucosal surface and body tissue | |
JP2001302502A (en) | Indomethacin percutaneous patch material | |
JPS63189484A (en) | Pressure-sensitive adhesive composition for oral mucosal application agent | |
JPS63171565A (en) | Constitutional body for adhesion of mucous membrane of oral cavity and its production | |
JPS63174660A (en) | Adhesive composition for being adhered to viscous membrane of oral cavity | |
JPS6393717A (en) | Sticking agent or adhesive agent for oral mucosa | |
JPS61122211A (en) | Gradually releasing adhesive for oral mucosa | |
JPH01101975A (en) | Plaster for mucous membrane | |
JPS63265983A (en) | Hydrophilic self-adhesive composition | |
AU769500B2 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
JPS63201120A (en) | Tacky adhesive composition for plaster to be applied to oral mucosa | |
JPS63171564A (en) | Constitutional body for adhesion of mucous membrane of oral cavity and its production | |
JPS63265981A (en) | Hydrophilic self-adhesive composition | |
JPH01113054A (en) | Poultice for mucous membrane of oral cavity | |
JP2716195B2 (en) | Oral bandage | |
JPS63146972A (en) | Hydrophilic tacky adhesive composition | |
JPH01113056A (en) | Poultice composition for mucous membrane of oral cavity |